SPONSORED CONTENT Apexus remarked in October 2023, “It’s no longer a question of whether you’ll be audited; it’s a matter […]
SPONSORED CONTENT Routine data analysis can be one of the most effective tools for navigating the complexities of the 340B […]
SPONSORED CONTENT Experts from across the US come together each year to conquer the complex, ever-evolving Medicaid drug rebate and […]
SPONSORED CONTENT David Alexander currently serves as AIDS Health Care Foundation’s (AHF) Advocacy Mobilizer in Columbia, South Carolina. He is constantly […]
SPONSORED CONTENT With the hottest weather of the summer and the hottest topics to go with it, the 340B Coalition […]
SPONSORED CONTENT As I write this, we’re reaching the end of what’s “officially” LGBTQ+ Pride Month. The first Pride marches […]
SPONSORED CONTENT While federal laws and regulations set the foundation for 340B compliance, state-level laws introduce an additional layer of […]
SPONSORED CONTENT As the 340B program continues to grow in complexity, given the drug manufacturer restrictions, it is more important […]
SPONSORED CONTENT Artificial Intelligence (AI) is making significant strides in healthcare, and its potential impact on the 340B Drug Pricing […]
SPONSORED CONTENT In the complex landscape of healthcare, compliance with the Health Resources and Services Administration’s (HRSA) 340B program is […]